Skip to content
LookupMeds

Active ingredient

Aprepitant

21 finished FDA listings contain Aprepitant as their only active ingredient.

See all listingsCompare with another medication

FDA NDC Directory

Ingredient names as written by FDA
APREPITANT
Dosage forms
Capsule, Emulsion, Injection, Emulsion, Powder, For Suspension
Routes
Intravenous, Oral
Manufacturers / labelers
7
Strengths listed
125 mg/1 · 130 mg/18ml · 32 mg/4.4ml · 40 mg/1 · 80 mg/1
Brand names in FDA listings
Aponvie, Cinvanti, Emend

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 358255

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 021549MSD2003-03-263
ANDA 090999SANDOZ2012-09-243
NDA 207865MSD MERCK CO2015-12-171
ANDA 207777GLENMARK SPECLT2017-10-126
NDA 209296HERON THERAPS INC2017-11-091
ANDA 211835TORRENT2020-10-216
NDA 216457HERON THERAPS INC2022-09-161

Official labeling on DailyMed

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.